Literature DB >> 23644028

Pathway analysis of a genome-wide association study in schizophrenia.

Young Ho Lee1, Jae-Hoon Kim, Gwan Gyu Song.   

Abstract

OBJECTIVE: The aim of this study was to identify the candidate single nucleotide polymorphisms (SNPs) and candidate mechanisms that contribute to schizophrenia susceptibility and to generate a SNP to gene to pathway hypothesis using an analytical pathway-based approach.
METHODS: We used schizophrenia GWAS data of the genotypes of 660,259 SNPs in 1378 controls and 1351 cases of European descent after quality control filtering. ICSNPathway (Identify candidate Causal SNPs and Pathways) analysis was applied to the schizophrenia GWAS dataset. The first stage involved the pre-selection of candidate SNPs by linkage disequilibrium analysis and the functional SNP annotation of the most significant SNPs found. The second stage involved the annotation of biological mechanisms for the pre-selected candidate SNPs using improved-gene set enrichment analysis.
RESULTS: ICSNPathway analysis identified fifteen candidate SNPs, ten candidate pathways, and nine hypothetical biological mechanisms. The most strongly associated potential pathways were as follows. First, rs1644731 and rs1644730 to RDH8 to estrogen biosynthetic process (p<0.001, FDR<0.001). The genes involved in this pathway are RDH8 and HSD3B1 (p<0.05). All-trans-retinol dehydrogenase (RDH8) is a visual cycle enzyme that reduces all-trans-retinal to all-trans-retinol in the presence of NADPH. The chemical reactions and pathways involved result in the formation of estrogens, which are C18 steroid hormones that can stimulate the development of female sexual characteristics. Second, rs1146031 to ACVR1 to mesoderm formation and activin binding (p<0.001, FDR=0.032, 0.034). Two of 15 candidate genes are known genes associated with schizophrenia: KCNQ2 and APOL2. One of the 10 candidate pathways, estrogen biosynthetic process, is known to be associated with schizophrenia (p<0.001, FDR<0.001). However, 13 of candidate genes (RDH8, ACVR1, PSMD9, KCNAB1, SLC17A3, ARCN1, COG7, STAB2, LRPAP1, STAB1, CXCL16, COL4A4, EXOSC3) and 9 of candidate pathways were novel.
CONCLUSION: By applying ICSNPathway analysis to schizophrenia GWAS data, we identified candidate SNPs, genes like KCNQ2 and APOL2 and pathways involving the estrogen biosynthetic process may contribute to schizophrenia susceptibility. Further analyses are needed to validate the results of this analysis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23644028     DOI: 10.1016/j.gene.2013.04.014

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  25 in total

1.  The gender-specific association of CXCL16 A181V gene polymorphism with susceptibility to multiple sclerosis, and its effects on PBMC mRNA and plasma soluble CXCL16 levels: preliminary findings.

Authors:  Ljiljana Stojković; Aleksandra Stanković; Tamara Djurić; Evica Dinčić; Dragan Alavantić; Maja Zivković
Journal:  J Neurol       Date:  2014-05-23       Impact factor: 4.849

Review 2.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

3.  Myriad roles of voltage-activated potassium channel subunit Kvβ1.1 in the heart.

Authors:  Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

4.  A Schizophrenia-Related Deletion Leads to KCNQ2-Dependent Abnormal Dopaminergic Modulation of Prefrontal Cortical Interneuron Activity.

Authors:  Se Joon Choi; Jun Mukai; Mirna Kvajo; Bin Xu; Anastasia Diamantopoulou; Pothitos M Pitychoutis; Bin Gou; Joseph A Gogos; Hui Zhang
Journal:  Cereb Cortex       Date:  2018-06-01       Impact factor: 5.357

5.  Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling.

Authors:  Zhengshan Liu; Mikhail Osipovitch; Abdellatif Benraiss; Nguyen P T Huynh; Rossana Foti; Janna Bates; Devin Chandler-Militello; Robert L Findling; Paul J Tesar; Maiken Nedergaard; Martha S Windrem; Steven A Goldman
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

6.  Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.

Authors:  XiaoCan Jia; YongLi Yang; YuanCheng Chen; ZhiWei Cheng; Yuhui Du; Zhenhua Xia; Weiping Zhang; Chao Xu; Qiang Zhang; Xin Xia; HongWen Deng; XueZhong Shi
Journal:  J Affect Disord       Date:  2018-07-17       Impact factor: 4.839

7.  Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes.

Authors:  Tune H Pers; Pascal Timshel; Stephan Ripke; Samantha Lent; Patrick F Sullivan; Michael C O'Donovan; Lude Franke; Joel N Hirschhorn
Journal:  Hum Mol Genet       Date:  2016-01-10       Impact factor: 6.150

Review 8.  Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus.

Authors:  Yutaka Mizuki; Shinji Sakamoto; Yuko Okahisa; Yuji Yada; Nozomu Hashimoto; Manabu Takaki; Norihito Yamada
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

9.  ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin.

Authors:  Jian Chen; Mingyan Lin; Anastasia Hrabovsky; Erika Pedrosa; Jason Dean; Swati Jain; Deyou Zheng; Herbert M Lachman
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

10.  MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.

Authors:  Matthew F Buas; Lynn Onstad; David M Levine; Harvey A Risch; Wong-Ho Chow; Geoffrey Liu; Rebecca C Fitzgerald; Leslie Bernstein; Weimin Ye; Nigel C Bird; Yvonne Romero; Alan G Casson; Douglas A Corley; Nicholas J Shaheen; Anna H Wu; Marilie D Gammon; Brian J Reid; Laura J Hardie; Ulrike Peters; David C Whiteman; Thomas L Vaughan
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.